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Brown adipose tissue (BAT) is an energy-dispensing
thermogenic tissue that plays an important role in
balancing energy metabolism. Lineage-tracing
experiments indicate that brown adipocytes are
derived from myogenic progenitors during embry-
onic development. However, adult skeletal muscle
stem cells (satellite cells) have long been considered
uniformly determined toward the myogenic lineage.
Here, we report that adult satellite cells give rise to
brown adipocytes and that microRNA-133 regulates
the choice between myogenic and brown adipose
determination by targeting the 30UTR of Prdm16.
Antagonism of microRNA-133 during muscle regen-
eration increases uncoupled respiration, glucose
uptake, and thermogenesis in local treated muscle
and augments whole-body energy expenditure,
improves glucose tolerance, and impedes the devel-
opment of diet-induced obesity. Finally, we demon-
strate that miR-133 levels are downregulated in
mice exposed to cold, resulting in de novo genera-
tion of satellite cell-derived brown adipocytes.
Therefore, microRNA-133 represents an important
therapeutic target for the treatment of obesity.
INTRODUCTION
Obesity is associated with increased risks of type 2 diabetes,
cardiovascular diseases, and cancer and thus poses
a demanding challenge for global health care. Although diet
and exercise are well-known defenses against obesity, the exac-
erbating epidemic of obesity has raised a major interest to
develop alternative therapeutic strategies. Two distinct types
of adipose tissues exist—white and brown. When dietary energy210 Cell Metabolism 17, 210–224, February 5, 2013 ª2013 Elsevier Inexceeds total body energy needs, the energy is stored mainly as
triglycerides in white adipocytes. By contrast, brown adipocytes
are specialized to dissipate energy in the form of body heat (ther-
mogenesis) and are characterized by expression of uncoupling
protein Ucp1 in their abundant mitochondria (Frontini and Cinti,
2010).
Active brown adipose tissue (BAT) can provide a natural
defense against obesity. However, BAT is relatively scarce in
adult humans, and its prevalence was not unequivocally recog-
nized until recently (Cypess et al., 2009; Nedergaard et al.,
2007; Ouellet et al., 2012; Saito et al., 2009; van Marken Lichten-
belt et al., 2009; Virtanen et al., 2009; Zingaretti et al., 2009).
Intriguingly, the level of BAT activity in adult humans is negatively
correlated to body mass index (Cypess et al., 2009; Nedergaard
et al., 2010; Pfannenberg et al., 2010; van Marken Lichtenbelt
et al., 2009). Experimental induction of BAT function in animal
models is associated with a lean and healthy phenotype (Ghor-
bani and Himms-Hagen, 1997; Kopecky et al., 1995). As such,
expanding and activating BAT thermogenesis opens a new
avenue toward preventing/treating obesity and obesity-related
metabolic disorders (Cypess and Kahn, 2010).
Lineage-tracing experiments have indicated that BAT is
derived during embryogenesis from Pax7/Myf5-expressing skel-
etal muscle precursors located within dermomyotome (Atit et al.,
2006; Lepper and Fan, 2010; Seale et al., 2008). Importantly,
Prdm16, a zinc-finger transcription factor, has been demon-
strated to be necessary and sufficient to establish the identity
of the BAT lineage (Seale et al., 2007, 2008). In vitro, loss of func-
tion of Prdm16 promotes the myogenic differentiation of
committed preadipocytes isolated from BAT, whereas Prdm16
gain of function leads to brown adipogenesis of the C2C12
myoblast cell line and myoblasts isolated from newborn mice
(Seale et al., 2008). Similarly, Prdm16 is also both necessary
and sufficient for the emergence of beige adipocytes in subcuta-
neous WAT (browning), which is linked with improved metabolic
phenotypes (Seale et al., 2011).
Prdm16 determines BAT identity by activating the complete
complement of brown fat genes while also repressingc.
Figure 1. Satellite Cells Differentiate into Brown Adipocytes
(A) Satellite cells differentiated into brown adipocytes (arrowheads) in myofiber
cultures under proadipogenic conditions. Myofibers (n > 600) with resident
satellite cells were isolated from Pax7-CreER/R26R-tdTomato EDL muscles
and cultured for 12 days in proadipogenic medium. Lineage-marked satellite
cell-derived brown adipocytes expressed tdTomato and Prdm16, Perilipin A.
(B) Clonal analysis of FACS-isolated single satellite stem cells and satellite
myogenic progenitors (n > 2,000 for each cell type) indicates some satellite
cells are bipotential. Approximately 1.6% of satellite stem cells and 3.3%
satellite myogenic progenitors gave rise to mixed muscle and adipocyte-
containing colonies. In addition, 6.5% of satellite stem cells clones but none of
satellite myogenic progenitors gave rise to colonies uniformly composed of
adipocytes. Shown are representative images of three types of clones derived
from clonal satellite cell cultures stained with ORO, and the corresponding
percentages from satellite stem cells (Myf5) and satellite myogenic progen-
itors (Myf5+) clones.
See also Figure S1.
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programs (Seale et al., 2008). Notably, ablation of Prdm16 in
BAT abolishes the expression of brown adipocyte-specific ther-
mogenic genes (e.g., Ucp1), yet spares the terminal adipogenic
differentiation and the expression of adipogenic markers that are
common to both white and brown adipocytes (Seale et al., 2008).
As such, Prdm16 represents a ‘‘master regulator’’ of brown
adipogenesis particularly critical for brown adipose lineage
determination.
The potent fate-switching function of Prdm16 in vitro implies
that its expression be tightly regulated in myogenic cells in vivo.
Satellite cells are adult skeletal muscle stem cells, which reside
closely juxtaposed with contractile myofibers beneath the basal
lamina (Charge´ and Rudnicki, 2004). Satellite cells are quiescent
in vivo under physiological conditions, whereas they can be acti-
vated in response to resistance training or muscle injury. When
activated, satellite cells migrate from the myofibers and prolif-
erate as committed myogenic precursors (myoblasts), which in
turn undergo terminal myogenic differentiation (myogenesis)
and fuse into multinucleated muscle cells (myotubes) (Charge´
and Rudnicki, 2004). Notably, satellite cells are believed to be
uniformly committed to the myogenic lineage, and it has been
reported that they do not differentiate into adipocytes in vitro
(Joe et al., 2010). This is consistent with the observation that
Prdm16 is not detectable in satellite cells nor their daughter
myogenic precursor cells (Seale et al., 2011).
Here we show that satellite cells are multipotent and can give
rise to both myogenic and brown adipogenic lineages. The
brown adipose determination of satellite cells is controlled by
a myogenic microRNA, miR-133 that directly targets the 30UTR
of the Prdm16 mRNA to repress Prdm16 expression. Inhibition
of microRNA-133 during muscle regeneration elicits brown adi-
pogenic commitment of satellite cells in vivo and induces their
differentiation into interstitial brown adipocytes. Cold exposure
results in downregulation of miR-133 and de novo generation
of satellite cell-derived brown adipocytes. Taken together,
our data reveal a central function of miR-133 in controlling
Prdm16-dependent lineage determination of satellite cells and
suggest a promising strategy for inducing active BAT in vivo
from skeletal muscle stem cells.
RESULTS
Single Satellite Cells Are Multipotent and Differentiate
into Brown Adipocytes
In adult muscle, satellite cells are characterized by their specific
expression of Pax7 in both quiescent and activated states (Seale
et al., 2000). To investigate the capability of satellite cells in adult
skeletal muscle to undergo brown adipogenic differentiation, we
utilized a Cre/LoxP-based system for satellite cell lineage tracing
(Nishijo et al., 2009). Pax7-CreER;R26R-tdTomato mice were
injected with tamoxifin for 5 consecutive days at 6 weeks of
age to induce permanent tdTomato expression in satellite cells
and their descendants (see Figure S1A online).
From the extensor digitorum longus (EDL) muscles of these
mice, we isolated single myofibers (n > 600), carrying labeled
satellite cells embedded within their native niche, and cultured
them under established proadipogenic conditions (Seale et al.,
2008). We observed adipocytes at a low frequency, character-Cell Mized by the presence of oil droplets and expression of cyto-
plasmic Perilipin A (a marker for differentiated adipocytes),
mixed together with elongated multinucleated myotubes
(Figure 1A). Importantly, these adipocytes were brown adipo-
cytes, as evidenced by their nuclear expression of Prdm16 (Fig-
ure 1A). As expected, all multinucleated myotubes were labeled
with tdTomato, indicating their satellite cell origin. Notably,
Prdm16pos brown adipocytes were similarly labeled with
tdTomato, indicating that they derived from Pax7-expressing
satellite cells (Figure 1A). Overall, satellite-cell-derived brown
adipocytes (SC_BA) accounted for 0.1% of tdTomato-labeled
cells in these cultures. By contrast, brown adipogenic differenti-
ation of satellite cells was not observed under promyogenic
culture conditions (Kuang et al., 2007) (Figure S1B).
Satellite cells represent a heterogeneous population contain-
ing stem cells and committed cells (Wang and Rudnicki, 2012).etabolism 17, 210–224, February 5, 2013 ª2013 Elsevier Inc. 211
Figure 2. Prdm16 Is Targeted by miR-133
(A) Prdm16 30UTR contains a conserved target site for both miR-133a and miR-133b. The absolutely conserved 8 nt seed sequences in multiple genomes and
a mutated seed sequence used in this study (Prdm16_mutUTR) were enclosed in a red frame.
(B) Luciferase assays and RT-qPCR indicate miR-133 targets Prdm16 30UTR and this repression depends on the predicted 8 nt seed sequence. Ectopic miR-133
was overexpressed in HEK293T cells together with Renilla luciferase reporter constructs containing either intact or mutated Prdm16 30UTR. The repression of
luciferase activity and expression by miR-133 was abolished by mutating the predicted 8 nt seed sequence.
(legend continued on next page)
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cell population (Pax7pos, Myf5-Cre-YFPneg) that can undergo
asymmetric cell divisions to generate committed satellite
myogenic progenitors (Pax7pos, Myf5-Cre-YFPpos) (Kuang
et al., 2007). To measure the potential of these two satellite cell
subpopulations to undergo brown adipogenesis, we employed
fluorescence-activated cell sorting (FACS) to isolate total satel-
lite cells from Pax7-ZsGreen;Myf5-Cre;R26R-tdTomato mice
on the basis of their ZsGreen fluorescence (Bosnakovski et al.,
2008), and further separate into satellite stem cell (ZsGreenpos,
Myf5-Cre-tdTomatoneg) and satellite myogenic progenitor
(ZsGreenpos, Myf5-Cre-tdTomatopos) subpopulations by tdTo-
mato fluorescence (Figures S1C and S1D).
To address whether these two subpopulations of satellite cells
aremultipotent (myogenic and adipogenic) at the clonal level, we
sorted single satellite stem cells or satellite myogenic progeni-
tors into individual wells (n > 2,000 for each cell type). The reli-
ability of sorting single satellite cells into individual wells was
confirmed by visual inspection of all wells (Figure S1E). We found
that 6.5% of single satellite stem cell-derived clones contained
exclusively oil red O (ORO)-positive adipocytes, whereas this
kind of clone was not observed from satellite myogenic progen-
itor clones (Figure 1B, left). Notably, 1.6% of satellite stem cell
clones and 3.3% of satellite progenitor clones contained mixed
adipocytes and myotubes, supporting the notion that satellite
cells are multipotent (Figure 1B, middle). The majority of satellite
cell clones exclusively formed muscle-containing colonies (Fig-
ure 1B, right). These data demonstrate that satellite cells are
multipotent and can clonally give rise to both myogenic and
brown adipogenic cells.
Prdm16 Is Targeted by miR-133
We hypothesized that brown adipose determination of satellite
cells is controlled by microRNAs, which regulate the expression
of Prdm16 or other brown adipose determinants. Therefore, we
performed whole-transcriptome RNA sequencing (RNA-Seq)
for satellite cells and brown preadipocytes isolated from adult
hindlimb muscles and interscapular BAT (iBAT), respectively,
by established FACS schemes (Scime` et al., 2005) (Figure S2A).
We identified 580mRNAs and 88microRNAs, which are differen-
tially expressed between two cell lineages (Figures S2B and
S2C, Table S1, and Table S2).
Satellite cell-enriched microRNAs and their predicted tran-
scription factor targets enriched in brown preadipocytes were
plotted to identify negative regulatory networks (Figure S2D).
Analysis of the network suggested that Prdm16 is repressed
by the satellite cell-enriched miR-133a and miR-133b. We iden-
tified a highly conserved target site for miR-133a and miR-133b
with an absolutely conserved 8 nt seed sequence in the 30UTR of(C) Immunoblots reveals that lentiviral miR-133 overexpression (ov.) in primary b
(D) Representative images depict that adipogenic differentiation from primary b
staining revealed drastically reduced number of differentiated adipocytes with o
indicated that same near-confluent density of cells were present for both culture
(E) RT-qPCR shows lentiviral overexpression of miR-133 or inhibition of miR-133
primary brown preadipocytes, respectively. Notably, impaired brown adipogenic
myogenic differentiation, as evidenced by increased expression of myogenic m
evidenced by increased expression of Leptin.
Error bars, SEM. See also Figure S2.
Cell MPrdm16 mRNA (Figure 2A). The conservation of the seed
sequence suggests biological relevance of these microRNAs in
regulating Prdm16 expression in humans.
We performed luciferase assays and RT-qPCR to investigate
the direct targeting of Prdm16 30UTR by miR-133. HEK293T
cells transfected with reporter plasmids containing the
Prdm16 30UTRs showed markedly decreased luciferase activity
and luciferase mRNA level in the presence of ectopic miR-133
(Figure 2B). Mutation of the conserved 8 nt seed sequence
abrogated the miR-133-induced repression of the Prdm16
30UTR. Similar results were also observed in C2C12 myoblasts
(Figure S2E).
miR-133 belongs to a group ofmyomiRs, which are enriched in
muscle tissue and myogenic cells (Chen et al., 2006; Williams
et al., 2009). We confirmed the inverse expression patterns of
Prdm16 and miR-133 in FACS-sorted BAT progenitors, satellite
cell populations, and cultured primary myoblasts (Figure S2F).
Thus, we hypothesized that direct targeting of Prdm16 by
miR-133 represents a potential regulatory mechanism in brown
adipose determination.
Overexpression of miR-133 Impairs Lineage
Commitment of Brown Preadipocytes
Primary brown preadipocytes express low but evident levels of
miR-133 (Walden et al., 2009). Therefore, we tested the effects
of miR-133 overexpression on the brown adipose lineage fate
of primary brown preadipocytes. To avoid ‘‘off-target’’ and
‘‘overloading’’ side effects, we utilized a lentivirus-based micro-
RNA expression system to elevate the endogenous levels of
miR-133 in primary brown preadipocytes within a physiological
range.
Lentiviral overexpression of miR-133 resulted in markedly
reduced protein levels of Prdm16 and Pgc1-a, which is
a Prdm16 target and critical for BAT-specific thermogenic
gene expression (Seale et al., 2007) (Figure 2C). Moreover, over-
expression of miR-133 strongly impaired adipogenic differentia-
tion of brown preadipocytes at confluent density, as evidenced
by reduced number of OROpos adipocytes in the differentiation
cultures (Figure 2D).
We further performed RT-qPCR to investigate gene expres-
sion signatures associated with lineage commitment of brown
preadipocytes in response tomiR-133 overexpression or repres-
sion (Figure 2E). Overexpression of miR-133 decreased the
expression of brown adipogenic markers (Prdm16, Pgc1a,
Ucp1, Cidea, and miR-196a) as well as genes associated with
general adipogenesis (Pparg, Fabp4, Cebpb, and Adipoq).
Notably, overexpression of miR-133 led to markedly increased
expression levels of myogenic transcription factors, Pax7,
MyoD, and Myogenin as well as a myogenic differentiationrown preadipocytes repressed Prdm16 and Pgc1-a protein levels.
rown preadipocytes was severely impaired by miR-133 overexpression. ORO
il droplets in the miR-133 ov. culture, while DAPI staining of the same fields
s.
by antisense oligos impaired or enhanced brown adipogenic commitment in
commitment in the miR-133 ov. culture was companied with the emergence of
arkers (Pax7, MyoD, Myog, MyHC), and white adipogenic differentiation, as
etabolism 17, 210–224, February 5, 2013 ª2013 Elsevier Inc. 213
Figure 3. miR-133 Prevents Brown Adipose Determination in Satel-
lite Cells
(A) Inhibition of miR-133 induced satellite cells to differentiate into brown
adipocytes (arrowheads) in myofiber cultures under proadipogenic condi-
tions. Myofibers (n > 300) with resident satellite cells were isolated from Pax7-
CreER/R26R-tdTomato EDLmuscles and transfected with mixed inhibitors for
miR-133a and miR-133b or a control scramble inhibitor. Lineage-marked
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specific marker, Leptin, was also increased in miR-133 overex-
pression culture. By contrast, inhibition of miR-133 enhanced
brown adipogenic commitment and differentiation, as evidenced
by increased expression of Prdm16, Pgc1a,Ucp1,Cidea, Pparg,
Cebpb, and Adipoq, as well as decreased expression of Pax7,
MyoD, Myogenin, and MyHC (Figure 2E). These data indicate
that miR-133 regulates brown adipose determination in primary
brown preadipocytes by targeting Prdm16.
miR-133 Prevents Brown Adipose Determination
in Satellite Cells
To investigate whether knockdown of miR-133 promotes brown
adipose determination, we transfected satellite cells embedded
within individual myofibers with mixtures of either antisense
oligonucleotide (ASO) inhibitors or mimetics for miR-133a and
miR-133b (>300 myofibers per treatment group) (Figure S3A).
Remarkably, inhibition of miR-133 resulted in a pronounced
increase of brown adipocytes in the culture, characterized by
their nuclear Prdm16 staining and presence of oil droplets (Fig-
ure S3B, right). Conversely, no brown adipocytes were observed
in myofiber cultures transfected with miR-133 mimetics (Fig-
ure S3B, middle).
To confirm that these brown adipocytes were derived from
satellite cells, tdTomato-labeled satellite cells on myofibers iso-
lated from Pax7-CreER;R26R-tdTomato mice (>300 myofibers
per treatment group) were transfected with miR-133 ASO inhib-
itors (Figure 3A). Notably, we observed a dramatic 16-fold
increase in the number of satellite cell-derived brown adipocytes
(SC_BA), as evidenced by their Ucp1 and tdTomato double
staining in response to miR-133 inhibition (Figure 3A). Thus, we
conclude that miR-133 inhibition in satellite cells is sufficient to
induce brown adipose determination.
The molecular nature of SC_BA was characterized following
their enrichment by centrifugation based on their low density.
After centrifugation, the supernatant fraction was enriched for
SC_BA, whereas the pellet fraction was enriched for myotubes.
The gene expression profiles of these SC_BA and myotube frac-
tions were then compared with those of cultured differentiated
brown preadipocytes originally also isolated from Pax7-
CreER;R26R-tdTomato mice (Figure 3B). RT-qPCR revealed
that the SC_BA-enriched supernatant fraction contained compa-
rable levels of tdTomatomRNA relative to the myotube-enriched
pellet fraction, consistent with the common satellite cell origin of
these two types of cells. By contrast, the preadipocyte-derived
brown adipocytes did not express tdTomato, confirming that
Pax7 was not expressed in iBAT during tamoxifen induction.
Intriguingly, SC_BA expressed a high level of Ucp1 but less
Prdm16 relative to brown adipocytes, suggesting that a low level
of Prdm16 is sufficient to support brown adipocyte determinationsatellite cell-derived brown adipocytes (SC_BA) expressed tdTomato and
Ucp1.
(B) RT-qPCR reveals gene expression signatures of SC_BAs as compared to
those of myotubes and differentiated primary brown adipocytes. miR-133
inhibitor-treated myofiber cultures were centrifuged to separate the super-
natant faction enriched for SC_BAs and the pellet fraction which contains
mostly myotubes.
Error bars, SEM. See also Figure S3.
c.
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tained lowermiR-133 levels relative to brown adipocytes. As ex-
pected, the myotube fraction was enriched for miR-133, Pax7,
and MyHC yet devoid of Ucp1 mRNA. Taken together, these
data support the hypothesis that miR-133 expression enforces
myogenic commitment of satellite cells by targeting Prdm16
expression and repressing brown adipogenic determination.
We next investigated whether miR-133 represses brown
adipose determination by targeting genes in addition to
Prdm16. To address this question, we transiently expressed
ectopic miR-133 in C3H10T1/2 mesenchymal progenitors in
the absence or presence of ectopic Prdm16 lacking its 30UTR
(Prdm16_CDS) during the adipogenic determination stage
(before adipogenic induction). In this manner, we could assess
whether miR-133 targets any other brown adipogenic determi-
nants during adipogenic determination, whose repression
cannot be rescued by Prdm16 ectopic expression (Figure S3C).
In the absence of Prdm16, ectopic expression of miR-133
moderately compromised the white adipose determination and
differentiation of C3H10T1/2 progenitors, as evidenced by
reduced Perilipin A expression combined with lack of Prdm16
or Ucp1 expression (Figures S3D and S3E). On the other hand,
ectopic expression of Prdm16 markedly promoted brown
adipose determination and differentiation, as evidenced by
increased Perilipin A expression combined with strong induction
of Ucp1 and Pgc1a. Critically, ectopic expression of miR-133
together with Prdm16 led to a comparable, if not improved,
brown adipocyte phenotype as compared to Prdm16 overex-
pression alone. In addition, overexpression of miR-133 alone in
C3H10T1/2 progenitors appeared not to inducemyogenic deter-
mination as observed from brown preadipocyte cultures (Fig-
ure S3E, MyHC panel). These findings are consistent with the
absence of miR-133 seed sequence in the 30UTRs of Pparg,
Pgc1a/b, Cebpa/b/d, and Ucp1. Therefore, we conclude that
miR-133 prevents brown adipose determination by primarily tar-
geting Prdm16.
Antagonism of miR-133 Induces Brown Adipose
Determination of Satellite Cells during Muscle
Regeneration
To investigate miR-133 function in brown adipose determination
of satellite cells in vivo, we synthesized miR-133 antagomiR
(miR-133 ASO) with an antisense sequence to both miR-133a
and miR-133b, as well as a control ‘‘antagomiR’’ (control ASO)
with the same chemical modifications and not antisense to any
mouse gene or EST sequence (see the Experimental Proce-
dures). We performed lineage tracing to distinguish effects of
miR-133 ASO on satellite cells versus other cell types. Six-
week-old Pax7-CreER;R26R-tdTomato mice were treated with
tamoxifin as before (five consecutive daily injections), then
aged to 10 weeks of age prior to initiating the experiment.
Control ASO versus miR-133 ASO were injected into tibialis
anterior (TA) muscles 3 days following saline injection (quiescent
state) or cardiotoxin injection (to induce satellite cell activation)
(Figure S4A). After 1 month, RT-qPCR was performed using
RNA isolated from several tissues to evaluate the efficacy and
scope of miR-133 ASO administration.
We detected striking reduction of both miR-133a and miR-
133b expression within the TA muscles administrated withCell MmiR-133 ASO, with more prominent effects observed in resting
muscles injected with miR-133 ASO (Figure 4A). In fact, miR-
133 ASO injected into resting muscles also repressed miR-
133a/b expression in the contralateral TA muscles, suggesting
diffusion of this antagomiR under this condition. Such a ‘‘leaking’’
effect was not present when miR-133 ASO was injected into
regenerating muscles. Notably, miR-133 expression in the
myocardium was unaffected by the intramuscular administration
of miR-133 ASO. In addition, miR-133 ASO had no effect on
let-7a microRNA expression, confirming its specificity. Accord-
ingly, we detected increased Ucp1 mRNA within miR-133
ASO-injected regenerating muscle, yet not within other tissues
or miR-133 ASO-injected resting muscle (Figure 4A). Similar
repression ofmiR-133a/b and induction ofUcp1mRNAwere de-
tected after 3months of a single miR-133 ASO injection in regen-
erating muscle, indicating long-lasting effects of this ASO in
muscle (Figure S4B). Corroborating the RT-qPCR results, Ucp1
protein was specifically detected by immunoblotting of extracts
from regenerated TA muscles that had received miR-133 ASO,
but not in contralateral muscles or under other conditions
(Figure 4B and Figure S4C). By comparison, Ucp3, a muscle
abundant uncoupling protein, was largely unaffected by miR-
133 ASO administration (Figure 4B). miR-133 ASO treatment
following frozen injury-induced muscle regeneration similarly
induced Ucp1 mRNA level in treated TA muscle (Figure S4D).
To investigate whether miR-133 ASO was inducing satellite
cells to undergo brown adipose determination in vivo, we per-
formed immunofluorescence microscopy on cross-sections
prepared from regenerating TA muscles treated with control-
or miR-133 ASO (Figures 4C and 4D). Staining for Ucp1 and
basal lamina-located Laminin confirmed Ucp1 staining only
within miR-133 ASO-treated regenerating muscles. Moreover,
we found that Ucp1pos cells were located within muscle intersti-
tium, distinct from surrounding myofibers ensheathed within the
basal lamina (Figure 4C). In addition, we observed that these
interstitial cells were immunoreactive to Perilipin A and nuclear
Prdm16 (Figure 4D). Most importantly, the majority of these
induced brown adipocytes were also labeled with tdTomato,
indicating that they were derived from Pax7-expressing satellite
cells (Figures 4C and 4D).
We observed markedly increased numbers of interstitial cells
(Figure S4E) and ORO-stained cells (Figure S4F) located
between regenerating myofibers in response to miR-133 ASO
treatment. ASO-treated muscles contained on average
15.6 Ucp1pos brown adipocytes per section, of which 83.3%
were derived from satellite cells (Figure S4G). Also, each
cross-section of miR-133 ASO-treated muscle contained on
average 31.6 Prdm16pos cells, of which 76.8% were derived
from satellite cells (Figure S4H). Presumably, this difference
reflects the expression of Prdm16 in lineage-committed yet
undifferentiated brown preadipocytes. The remaining 20%
tdTomatoneg brown adipocytes may originate from unlabeled
satellite cells or from other cell sources (data not shown).
Small amounts of BAT have previously been reported to exist
in hindlimb muscles of obesity-resistant 129S6/SvEvTac mice,
but not in obesity-prone C57BL/6 mice (Almind et al., 2007).
By immunoblotting, we detected ectopically induced Ucp1
protein expression in miR-133 ASO-treated muscles (2 months
after treatment) of C57BL/6 mice fed with either a regular dietetabolism 17, 210–224, February 5, 2013 ª2013 Elsevier Inc. 215
Figure 4. Antagonism of miR-133 Induces Brown Adipose Determination of Satellite Cells during Muscle Regeneration
(A) High efficacy and specificity of miR-133 antagomiR (ASO) in vivo. RT-qPCR indicates reduced expression of bothmiR-133a and miR-133b, but not let-7a in
response to intramuscular miR-133 ASO administration. Ucp1 mRNA was drastically induced in regenerating TA muscles by miR-133 ASO.
(B) Immunoblots reveal the evident induction of Ucp1, but not Ucp3, in regenerating TAmuscles in response tomiR-133 ASO treatment. Asterisk denotes that the
loading of the iBAT lane on the Ucp1 immunoblot was 1/100 of other lanes to avoid overloading.
(C and D) miR-133 antagonism during muscle regeneration induced satellite cells to differentiate into brown adipocytes located within the muscle interstitium.
Representative images of TA muscle cross-sections stained with Ucp1 and Laminin (C) or Prdm16 and Perilipin A (D) together with tdTomato native fluorescence
revealed SC_BAs within the muscle interstitium.
Error bars, SEM. See also Figure S4.
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observe Ucp1 expression in either control ASO-treated muscles
or contralateral resting muscles under either diet condition. H/E
staining and Ucp1 immunohistochemistry further confirmed the
efficacy of miR-133 ASO in inducing ectopic Ucp1pos brown
adipocytes within muscle interstitium of C57BL/6 mice under
both diet conditions (2 months after treatment) (Figure 5B).216 Cell Metabolism 17, 210–224, February 5, 2013 ª2013 Elsevier InmiR-133 Antagonism Induces Metabolically Active
Brown Adipocytes in Muscle
We next investigated whether miR-133 ASO-induced BAT in
muscle is metabolic active and can function as authentic BAT.
To quantify bioenergetic effects of miR-133 ASO-induced BAT
in muscle, we performed high-resolution respirometry on TA
muscles after 2 months of either control or miR-133 ASOc.
Cell Metabolism
MicroRNA-133 Regulates Brown Adipose Determinationtreatment (C57BL/6 males fed on RD, n = 6 in each treatment
group). We applied a two-step protocol that was specifically
designed to reveal the metabolic functions of relatively rare
BAT embedded within skeletal muscle (see the Supplemental
Experimental Procedures). Compared to skeletal muscle, brown
adipocytes have conspicuously higher uncoupled respiration
rates particularly in response to fatty acids (FAs), which is due
to their characteristic expression of mitochondrial Ucp1 (Cannon
and Nedergaard, 2004). Thus, we first followed a well-estab-
lished protocol to measure FA-induced uncoupled respiration
in intact (nonpermeabilized) muscle preparations (Figure 5C)
(Chance and Williams, 1955). We found that titration of octanoyl
carnitine (amedium-chainFAcovalently linked to carnitine,which
can enter freely into intact cells and also into mitochrondrion via
acylcarnitine translocase [Houten andWanders, 2010]) increased
mitochondrial respiration rate to 13.5 ± 1 pmol$s1$mg1
in miR-133 ASO-treated TA muscle compared to 7.7 ±
1 pmol$s1$mg1 in control (Figure 5D, uncoupled/intact cells).
Thismarked difference in the response to FAs is highly consistent
with reported acute activation of mitochondrial respiration rates
in brown adipocytes exposed to FAs (Matthias et al., 2000).
We next sought to test whether this 1.75-fold increase in the
respiration rate was due to potential changes in muscle cells. If
these changes indeed occurred, we expected to detect similar
increased lipid oxidative phosphorylation capacity in permeabi-
lized muscle preparations (permeabilization allows various
substrates to pass through the cell membrane; see the Supple-
mental Experimental Procedures). We measured maximal elec-
tron flow through electron-transferring flavoprotein (ETF) in
a separate portion of TA muscles in the presence of ADP. In
response to ADP, the lipid oxidative phosphorylation capacity
was 13.0 ± 1 pmol$ s1$mg1 in the control muscle as compared
to 13.8 ± 3 pmol$s1$mg1 in the miR-133 ASO-treated muscles
(Figure 5D, ETF/permeabilized cells). This observation strongly
supports the notion that the higher respiration rate in intact
miR-133 ASO-treated muscle is due to FA-induced uncoupling
in brown adipocytes, not in muscle cells. Therefore, we estimate
that the induction of uncoupling respiration by miR-133 ASO
leads to an additional 0.3 cal$hr1$mg1 of energy expenditure
in the treated TA muscle.
To further investigate possible bioenergetic effects of miR-133
ASO on muscle cells, we compared coupled state 3 respiration
rates in treated and control permeabilized muscle tissues under
full electronsupply throughcomplexes I and II (Figure5D,permea-
bilizedcells).Nodifference inelectron transport throughcomplex I
(NADH dehydrogenase) between control and treated muscles
was observed after electron transport through ETF was inhibited
by the titration of glutamate (treated = 33 ± 3 pmol$s1$mg1,
control = 28 ± 2 pmol$s1$mg1, p = 0.2). Maximal cellular state
3 respiration or oxidative phosphorylation capacity (P I+II) was
induced with the addition of succinate to provide additional elec-
tron flow through complex II (succinate dehydrogenase). This
capacity reflects the maximal mitochondrial capacity to catalyze
Redox reactions that are primarily coupled to the production of
ATP via ATP synthase. Again, no difference in maximal coupled
respiration between control and miR-133 ASO-treated muscles
was observed (Figure 5D, P I+II/permeabilized cells). Similar
results were derived from contralateral soleus muscles of control
or miR-133 ASO-treated mice (Figure S5A). As both glutamateCell Mand succinate are poor substrates for BATmitochondria (Cannon
and Nedergaard, 2001), these results rule out any significant
bioenergetic effect of miR-133 ASO on skeletal muscle cells.
Altogether, these data support the assertion that miR-133
ASO treatment in regenerating muscle results in unaltered
coupled respiration in treated muscle cells but elicits drastic
increases in uncoupled respiration, presumably owing to ectop-
ically induced brown adipocytes within the muscle interstitium.
Metabolically active BAT has been identified in adult human by
[18F]-fluorodeoxyglucose positron emission tomography ([18F]-
FDG PET), due to dramatic glucose uptake by this tissue after
sympathetic activation (Nedergaard et al., 2007). To visualize
active BAT within muscle, we performed [18F]-FDG PET imaging
on control or miR-133 ASO-treated mice (n = 5 for 133 ASO-
treated mice, n = 4 for control-treated muscle; 2 months after
treatment) after acute sympathetic activation by selective b3-
adrenergic receptor agonist, CL316,243. We observed
a dramatic increase of FDG uptake in miR-133 ASO-treated TA
muscles compared to contralateral TA muscles or TA muscles
within control ASO-treated mice (Figure 5E and Figure S5B). To
rule out possible direct and indirect effects of CL316,243 on
glucose/FDG uptake by skeletal muscle cells, we normalized
FDG activities derived from regions of interest (ROIs) of treated
TA muscles to those of contralateral TA muscles (Figure 5F). On
average, miR-133 ASO-treated TA muscles after CL316,243-
stimulated sympathetic activation exhibited a 1.3-fold increase
of glucose/FDG uptake compared to control, strongly arguing
that the ectopic-induced brown adipocytes in miR-133 ASO-
treated TA muscles are metabolically active upon activation.
Such a drastic increase was not observed without the sympa-
thetic activation preceding anesthesia (baseline). As a reference,
glucose/FDG uptake by iBAT expectedly increased 2.3- to 2.5-
fold after CL316,243-stimulated sympathetic activation in both
control and miR-133 ASO-treated mice (Figure 5F).
A hallmark of active brown adipocytes is their unique thermo-
genic capability via extensive uncoupled respiration in abundant
mitochondria (Cannon and Nedergaard, 2004). Therefore,
we directly assessed the thermogenic capability of muscle-
embedded brown adipocytes by thermographic imaging of
control- or miR-133 ASO-treated mice fed with either RD or
HFD (n = 5 per treatment group per diet group; Figure 5G). We
observed increased surface temperatures on miR-133 ASO-
treated hindlimbs compared to contralateral hindlimbs or
hindlimbs of control ASO-treated mice (Figure 5G). On average,
the surface temperatures on miR-133 ASO-treated hindlimbs
were 0.7C or 0.9C higher than control hindlimbs for mice fed
with RD or HFD, respectively (Figure 5H). We observed no differ-
ence in expression of IL-1b and TNF-a between control and
treated muscles, supporting the assertion that the temperature
increase is not due to inflammation (Figure S5C).
Taken together, our data provide compelling evidence that the
induced intramuscular BAT induced by miR-133 ASO treatment
is metabolically active.
Antagonism of miR-133 during Muscle Regeneration
Reduced Adiposity, Augmented Energy Expenditure,
and Improved Glucose Tolerance
Intramuscular brown adipocytes have been described in 129S6/
SvEvTacmice and in Lxr/mice (deficient for Liver X receptors),etabolism 17, 210–224, February 5, 2013 ª2013 Elsevier Inc. 217
Figure 5. miR-133 Antagonism Induces Metabolically Active Brown Adipocytes in Muscle
(A) Immunoblots reveal the induction of Ucp1 in regenerating TAmuscles by miR-133 antagonism inC57BL/6mice fed with either a regular diet (RD) or a high-fat
diet (HFD). The contralateral TA muscles were included as control.
(B) Hematoxylin and eosin (H/E) staining and immunohistochemistry (IHC) of Ucp1 protein reveal that miR-133 antagonism-induced brown adipocytes located
within the muscle interstitium (arrowheads) under both diet conditions.
(C) Representative oxygraph tracings from high-resolution respirometry depict markedly increased uncoupled (nonphosphorylating) respiration in intact (non-
permeabilized) miR-133 ASO-treated TA muscles compared to control. Notably, octanoyl carnitine (OC) markedly increased the O2 consumption in miR-133
ASO-treated TAmuscles compared to control. Responses before reoxygenation (which showed no O2 diffusion limitation) and titration of antimycin A are shown.
(legend continued on next page)
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MicroRNA-133 Regulates Brown Adipose Determinationboth of which display increased energy expenditure and resis-
tance to obesity (Almind et al., 2007; Kalaany et al., 2005). We
therefore assessed systematic metabolic consequences of
miR-133 ASO treatment in regenerating TA muscle.
Treated and control C57BL/6male mice were raised on either
RD or HFD in individual cages at 22C (n = 5 per treatment per
diet group). In both diet groups, miR-133 ASO-treated mice
were obviously leaner than the control mice at 4 months after
treatment (Figure 6A). Quantitatively, miR-133 ASO-treated
mice displayed reduced gain in body weight over the 4 month
period after ASO administration (Figure 6B). Close examination
revealed significant reduction of weights in inguinal white fat
depots (igWAT) and epididymal white fat depots (epiWAT), yet
themass of iBAT depots and treated TAmuscles was unaffected
(Figure S6A).
To assess whether miR-133 ASO treatment leads to increased
whole-body energy expenditure, we carried out indirect calorim-
etry studies at 2–3 months after ASO treatment on control and
miR-133 ASO-treated mice (C57BL/6, male, individually caged,
n = 5 per treatment group per diet group; Figure 6C and Fig-
ure S6B). We detected a significant increase of total energy
expenditure inmiR-133 ASO-treatedmice during light cycle (Fig-
ure 6C, left) without change in physical activities (Figure 6D, left).
Intriguingly, this amount of energy expenditure is coincident with
the increase of mitochondrial respirometry-measured energy
expenditure in miR-133 ASO-treated TA muscles after adjust-
ment with TA muscle mass (Figure S6A; 0.3 cal$hr1$mg1 3
75mg = 0.0225 kcal$hr1). Thus, we reasoned that increased un-
coupled respiration due to ectopically induced intramuscular
BAT likely contributes significantly to the total energy expendi-
ture increase in light cycle. In dark cycle (when mice are active
and feeding), the energy expenditure is conspicuously high in
miR-133 ASO-treated mice (Figure 6C, right), which is associ-
ated with increased physical activities for the mice during the
dark cycle (Figure 6D, right).
Similarly, we detected significantly increased total energy
expenditure in miR-133 ASO-treated mice fed the HFD during
light cycle (Figure S6B, left), without a difference in physical
activities (Figure S6C, left). No significant increase in energy
expenditure or physical activity was recorded in these mice(D) High-resolution respirometry reveals a marked increase of uncoupled respira
levels of fatty acid b-oxidation-mediated electron transport through electron-tra
(P I+II) in control andmiR-133 ASO-treated, permeabilized TAmuscles (n = 6 per gr
was comparable to that of control muscle after titration of ADP (ETF).
(E) Representative 18F-FDG microPET/CT images of miR-133 ASO-treated mice
contralateral nontreated TA muscle in response to acute CL316,243 treatment.
senting clusters of active brown adipocytes, were only present withinmiR-133 ASO
cross-sections. The position of miR-133 ASO-treated TA muscle was demarcate
(F) Quantitative 18F-FDG activities within regions of interest (ROIs) reveal marke
CL316,243 treatment (n = 5 for miR-133 ASO-treated group, n = 4 for control ASO
muscles to those of contralateral TAmuscles in order to cancel out potential effec
18F-FDG uptake by interscapular BAT (iBAT) was also dramatically induced by C
(G) Representative thermographic images depict evident increase of surface temp
diet (RD, blue arrowhead) or a high-fat diet (HFD, green arrowhead) compared
Arrowheads denote ASO treated right hindlimbs. Whole-body thermographic imag
hindlimbs and neck areas.
(H) Quantitative temperature measurement by thermographic imaging reveals the
ASO treatment (n = 5 per treatment group per diet group).
Error bars, SEM. See also Figure S5.
Cell Mover the dark cycle when compared to control mice (Figures
S6B and S6C, right panels). This discrepancy may be related
to the abnormally low respiratory exchange ratio (0.76) in the
control mice fed with HFD (Figure S6D), which indicates an
increased proportion of lipid oxidation in the control mice. The
24 hr food intake in miR-133 ASO-treated mice was comparable
to that of control mice for both diet groups (Figure S6E), suggest-
ing the reduction of body weight is likely due to the enhanced
thermogenesis, and hence lower food efficiency, in the mice.
Intriguingly, miR-133 ASO treatment also led to much improved
glucose tolerance in both diet groups (Figure 6E and Figure S6F).
In addition, H/E staining and microscopy of tissue sections from
fat depots and liver revealed that miR-133 ASO-treated mice ex-
hibited reduced numbers of infiltrating inflammatory cells in epi-
WAT and reduced liver steatosis when fed the HFD (Figure S6G).
Notably, the body weight and glucose tolerance status of our
control mice resemble those of C57BL/6 mice (in the same
age) reported in numerous studies, which argues that the bene-
ficial effects of miR-133 ASO treatment was not due to any
cryptic effect of our control antagomiR.
Therefore, we conclude that miR-133 antagonism by ASO
injection during muscle regeneration elicits profound changes
in energy metabolism at the whole-body level, consistent with
a leaner and healthier phenotype.
The Expression ofmiR-133 Is Downregulated In Skeletal
Muscles after Cold Exposure, which Is Coincident with
Emergence of Satellite Cell-Derived Brown Adipocytes
We next investigated whether the brown adipose determination
of satellite cells occurs under physiological conditions that
downregulate miR-133 expression. It has been reported that
chronic cold exposure induces Ucp-1pos adipocytes (‘‘brite’’ or
‘‘beige’’ adipocytes), which morphologically resemble brown
adipocytes yet arise from a non-Myf5 cell lineage, in subcuta-
neous WAT (Frontini and Cinti, 2010; Seale et al., 2011). We per-
formed RT-qPCR using RNA isolated from multiple adipose and
muscle tissues to evaluate the expression of miR-133 and BAT
markers (Prdm16 and Ucp1) in response to cold exposure
(1 week at 4C; Figure 7A). We found cold exposure represses
the expression of miR-133 in all investigated skeletal muscletion in miR-133 ASO-treated TA muscles (intact cells) as well as comparable
nsferring flavoprotein (ETF) and maximal oxidative phosphorylation capacity
oup). Notably, the respiration rate inmiR-133 ASO-treated permabilizedmuscle
depict increased FDG uptake in the ASO-treated TA muscle compared to the
Notably, hot spots with extremely high 18F-FDG activities, presumably repre-
-treated TAmuscles. Dashed lines denote the levels for transverse and sagittal
d by dots on these cross-sections.
d increases of FDG uptake in miR-133 ASO-treated TA muscles after acute
-treated group). We normalized the 18F-FDG activities within ROIs of treated TA
t of CL316,243 or physical activity on FDG uptake in differentiated muscle cells.
L316,243.
eratures in themiR-133 ASO-treated hindlimbs of mice fed with either a regular
to the contralateral hindlimbs or both hindlimbs in control ASO-treated mice.
es (lower panels) are shown to denote the representative temperatures at both
marked increase of surface temperatures in hindlimbs that received miR-133
etabolism 17, 210–224, February 5, 2013 ª2013 Elsevier Inc. 219
Figure 6. Antagonism of miR-133 during Muscle Regeneration Reduced Adiposity, Increased Total Energy Expenditure, and Improved
Glucose Tolerance
(A) Representative images of direct comparisons of C57BL/6 mice fed the RD or HFD and received control or miR-133 ASO treatment during TA muscle
regeneration depict that the miR-133 ASO-treated mice displayed leaner phenotype.
(B) Retarded body weight increase over a 16 week body weight monitoring time course in mice that received miR-133 ASO treatment during TA muscle
regeneration (n = 6 per treatment group per diet group).
(C) miR-133 ASO treatment increased total energy expenditure. Indirect calorimetry reveals that mice receiving miR-133 ASO treatment during TA muscle
regeneration had a recorded higher energy expenditure than the control mice (n = 5 per group), measured at 22Cduring light and dark cycles (fed the RD). Values
of total energy expenditure were plotted without normalization to lean body mass.
(D) Physical activities measured within light and dark cycles during indirect calorimetry (C) reveal increased physical activities within the dark cycle for miR-133
ASO-treated mice (fed the RD). Physical activities are presented as arithmetic means of beam-breaking events at X, Y, and Z dimensions.
(E) IPGTT tests for C57BL/6 mice received either control or miR-133 ASO treatment (fed the RD; n = 6 per group).
Error bars, SEM. See also Figure S6.
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MicroRNA-133 Regulates Brown Adipose Determinationtissues and brown/white adipose tissues. Coincidently, induced
brown adipose determination/differentiation (as evidenced by
increased Prdm16 and Ucp1 mRNA levels) was also observed
in subcutaneous WAT depots and chunk muscles (e.g., inter-
costal muscles, back muscles, and paraspinal muscles), but
not limb muscles (e.g., tibialis anterior).
To confirm satellite cell-derived brown adipocytes were
induced by cold exposure, we performed immunofluorescence
microscopy on cross-sections prepared from paraspinal
muscles of cold-exposed Pax7-CreER;R26R-tdTomato mice.
Strikingly, we observed emerging tdTomatopos, Ucp1pos adipo-
cytes located within the interstitium of paraspinal muscles after
cold exposure (Figure 7B). Such adipocytes were not detected
in paraspinal muscles of the control Pax7-CreER;R26R-td
Tomato mice raised under room temperature (23C). Therefore,
our observations implicate miR-133 in the physiological regula-
tion of brown adipose determination of satellite cells in response
to cold exposure.220 Cell Metabolism 17, 210–224, February 5, 2013 ª2013 Elsevier InDISCUSSION
Using lineage tracing and clonal analysis, we found that satellite
cells in adult muscle are bona fide bipotential stem cells that can
give rise to brown adipogenic as well as myogenic progenitors.
We also identified a microRNA expressed in satellite cells and
upregulated as the myogenic program progresses—miR-133—
that directly represses the expression of Prdm16 to enforce
myogenic commitment in satellite cells. Thus miR-133 functions
as a switch to regulate the lineage choice between brown adipo-
genic versus myogenic determination.
We demonstrated that antagonizing miR-133 function by anti-
sense oligos (antagomiR) in activated satellite cells in response
to muscle injury resulted in the efficient induction of brown
adipocytes within the muscle interstitium. We estimate that
each treated TA muscle would contain tens of thousands of
brown adipocytes based on enumeration of these cells as well
as Ucp1 protein levels (Figure 4). Notably, the stimulatory effectc.
Figure 7. Cold Exposure Downregulates miR-133 Expression in Skeletal Muscles
(A) Cold exposure induced downregulation of miR-133 (miR-133a and miR-133b) in multiple adipose and muscle tissues and increased expression of brown
adipocyte markers, Prdm16 and Ucp1, in subcutaneous WAT and trunk muscles. C57BL/6 mice were raised under ambient temperature (23C) or exposed to
cold (4C) for 1 week. Multiple tissues were dissected and investigated by RT-qPCR for the expressions of miR-133, Prdm16, and Ucp1.
(B) Cold exposure induced satellite cells to differentiate into brown adipocytes located within the muscle interstitium in paraspinal muscles. Pax7-CreER;R26R-
tdTomatomice were raised under ambient temperature (23C) or exposed to cold (4C) for 1 week. Representative images of paraspinal muscle cross-sections
stained with DAPI, Ucp1, and Laminin together with tdTomato native fluorescence revealed SC_BAs within the muscle interstitium.
Error bars, SEM.
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MicroRNA-133 Regulates Brown Adipose Determinationof miR-133 ASO on brown adipose determination likely occurs in
the early stage of muscle regeneration (within 2 weeks after
muscle injury). Thus, satellite cell-derived brown adipocytes,
once formed, do not require constant exposure to miR-133
ASO to maintain their function. The targeting specificity of miR-
133 ASO argues for a pivotal role of miR-133 in BAT determina-Cell Mtion in muscle. However, it should also be noted that miR-133
may also target other biological processes in addition to de
novo BAT formation in vivo. Future studies will reveal whether
brown adipose determination of satellite cells occurs within
muscles of miR-133 compound mutant mice (miR-133a-1/;
miR-133a-2/; miR-133b/).etabolism 17, 210–224, February 5, 2013 ª2013 Elsevier Inc. 221
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MicroRNA-133 Regulates Brown Adipose DeterminationWe found that cold exposure represses the expression of
miR-133 in multiple skeletal muscle tissues along with brown
and white adipose tissues. Correspondingly, cold exposure
also induced brown adipose determination/differentiation (as
indicated by increased Prdm16 and Ucp1 mRNA levels) in
subcutaneous WAT depots and trunk muscles. To explore
whether the increased Prdm16/Ucp1 expression in trunk
muscles was due to induced satellite cell-derived brown adipo-
cytes, we further exposed Pax7-CreER;R26R-tdTomato mice to
cold and performed immunostaining (Figure S7B) on paraspinal
muscle cross-sections. Strikingly, we observed satellite cell-
derived brown adipocytes (tdTomatopos, Ucp1pos) located within
paraspinal muscle interstitium. Recently, it was reported that
miR-133 regulates Prdm16 in committed brown adipogenic
cells, and cold treatment of cultured cells resulted in down-
regulation of miR-133 and upregulation of Prdm16 and Ucp1
(Trajkovski et al., 2012). Taken together, these observations
implicate regulation of miR-133 expression as a key thermo-
regulatory mechanism in the whole-animal response to acute
and chronic cold.
Our investigation of themetabolic phenotypes associated with
miR-133 ASO-treated TA muscles/hindlimbs indicated that the
induced brown adipocytes in the muscle interstitium are meta-
bolically active (Figure 5). This notion is supported by bioener-
getics results of miR-133 ASO-treated TAmuscles in vitro, which
showed markedly increased uncoupled respiration in nonper-
meabilized miR-133 ASO-treated muscle in response to Ucp1
activation by FAs. This increased uncoupled respiration rate
has potentially important implications for energy expenditure
and weight control in vivo. The difference in uncoupled respira-
tion between control and miR-133 ASO treatment TA muscles
is equivalent to 0.023 kcal$hr1, which would fully account
for the measured difference of total energy expenditure between
control and miR-133 ASO-treated mice in the light cycle and
15% of the difference found in the dark cycle (when more
energy is used to support coupled, ATP synthase-dependent
respiration during physical activity).
Our experiments also demonstrate that miR-133 ASO induced
brown adipocytes in muscle function in the same manner as
authentic BAT, in terms of their energy uptake ([18F]-FDG/
glucose uptake; Figures 5E and 5F) and energy expenditure
(thermogenesis; Figures 5G and 5H). It is noteworthy that the
markedly increased glucose/FDG uptake in miR-133 ASO-
treated muscles was only revealed after selective b3-adrenergic
receptor activation (CL316,243). Importantly, b3-adrenergic
receptors express abundantly on brown adipocytes but little
on muscle cells (Krief et al., 1993).
Skeletal muscle is a compatible tissue for adaptive thermo-
genesis of resident brown adipocytes. It has been well estab-
lished that skeletal muscle cells are indirectly controlled by the
sympathetic nervous system via diffusible adrenergic transmit-
ters released from abundant vascular sympathetic innervations
(Bowman and Nott, 1969). Thus, it is reasonable to speculate
that interstitial satellite cell-derived brown adipocytes would be
readily accessed by catecholamines from the vasculature rela-
tive to myofibers surrounded by basal lamina. The elevated
glucose/FDG uptake in response to CL316,243 strongly impli-
cates the presence of b3-adrenergic receptors on satellite cell-
derived brown adipocytes.222 Cell Metabolism 17, 210–224, February 5, 2013 ª2013 Elsevier InSkeletal muscle has a very high metabolic capacity. There-
fore, it is intriguing to hypothesize that the activation of
muscle-embedded BAT may parallel sympathetic activation
and dynamic regulation of oxygen/energy source supply via
vasodilatation in response to need for muscle motor output.
Indeed, the obesity resistance trait of 129S6/SvEvTac mice
has been attributed to ectopic intramuscular BAT, which ap-
peared to be more sensitive to adrenergic agonists in Ucp1
induction as compared to iBAT (Almind et al., 2007). Similar to
129S6/SvEvTac mice, obesity-prone C57BL/6 mice showed
reduced adiposity, augmented energy expenditure, and
improved whole-body insulin sensitivity in response to miR-
133 ASO treatment and BAT induction in muscle (Figure 6).
These systemic effects of miR-133 ASO may associate with
direct effects of ectopically induced satellite cell-derived brown
adipocytes in muscle, or alternatively ensue from indirect effects
from reduced body weight and adiposity (e.g., increased muscle
insulin sensitivity may result from reduced adiposity or increased
physical activity).
The data from mitochondrial respirometry clearly indicate that
neither miR-133 ASO-treated TA muscles nor the contralateral
soleusmuscles have significantly increased oxidative phosphor-
ylation capacity compared to the control muscles (Figure 5D and
Figure S5A). The isolated activities of cytochrome oxidase in the
contralateral soleus muscles, a marker for mitochondrial content
(Larsen et al., 2012), were also comparable between treat-
ment groups (miR-133 ASO treated, 130 ± 13 pmol$s1$mg1;
control ASO treated, 113 ± 24 pmol$s1$mg1, p = 0.5).
These results indicate that the miR-133 ASO treatment regime
does not mimic a ‘‘training’’ effect in skeletal muscle cells.
Further investigation may shed light on the cause(s) of increased
physical activity levels in miR-133 ASO-treated mice. Never-
theless, the phenotypes linked with miR-133 ASO treatment
evidently argue for positive influences of miR-133 ASO on
metabolism.
Here, we demonstrate that satellite cells can differentiate into
either myocytes or brown adipocytes. The lineage switch
between myogenic and brown adipogenic commitment is
controlled by myomiR miR-133, which is highly expressed in
satellite cells. Functional brown adipocytes can be induced
from satellite cells by inhibiting miR-133 function during muscle
regeneration or by cold exposure accompanied with downregu-
lation of miR-133 expression. Therefore, targeting miR-133
activity in adult muscle stem cells represents an attractive
strategy to stimulate a physiological effective increase in the
numbers of active brown adipocytes in vivo.
EXPERIMENTAL PROCEDURES
Induced Brown Adipocytes In Vivo by miR-133 AntagomiR
To induce brown adipocytes in vivo, 10 mg/mL cardiotoxin solution (50 ml) was
intramuscularly injected into TA muscles of 10-week-old Pax7-CreER/R26R-
tdTomato mice (Figure 4) or C57BL/6 mice (Figure 5 and Figure 6). Alterna-
tively, frozen injury was performed by applying liquid nitrogen-cooled tweezers
tips directly onto the anterior sides of TA muscles (Figure S4H). After 3 days,
20 mg of miR-133 antagomiR or control antagomiR in saline (50 ml) was intra-
muscularly injected into the same injured TA muscles (on right hindlimbs). To
test efficacy of miR-133 ASO in intact muscles, saline, instead of cardiotoxin,
was injected to TA muscles before miR-133 ASO administration (Figures 4A
and 4B). miR-133 antagomiR and scramble antagomiR were designed as
previously described (Kru¨tzfeldt et al., 2005).c.
Cell Metabolism
MicroRNA-133 Regulates Brown Adipose DeterminationmiR-133 antagomiR sequence and modifications were as follows: 50-*mA*
mUmAmGmCmUmGmGmUmUmGmAmAmGmGmGmGmAmC*mC*mA*mA*
mAChl-30; scramble antagomiR sequence andmodifications, 50-*mA*mAmGm
AmAmUmGmAmCmGmAmUmCmGmGmUmAmGmG*mG*mC*mA*mCChl-30.
‘‘m’’ represents a 20-O-methyl-modified nucleotide. Asterisk indicates a phos-
phorothioate linkage. ‘‘Chl’’ denotes a 30 cholesterol moiety.
Indirect Calorimetry
Whole-body O2 consumption and CO2 production were measured using an
open-circuit four-chamber indirect calorimetry systemwith automatic temper-
ature and light controls (Columbus Instruments). Physical activities during indi-
rect calorimetry were measured using infrared laser beam sets. Mice had
access ad libitum to food and water in respiration chambers. Data were re-
corded for a 24 hr period with light between 06:00 and 18:00.
[18F]-FDG PET Imaging and X-ray Computed Tomography
All animal procedures comply with the Canadian Council on Animal Care’s
Guide to the Care and Use of Experimental Animals, the Animals for Research
Act, and were approved by the Animal Care Committee at University of
Ottawa. Mouse PET imaging was performed with an Inveon PET scanner
(Siemens Preclinical Solutions, Knoxville, TN, USA). Control or miR-133
ASO-treatedC57BL/6malemice fedwith regular diet were anesthetized under
2% isoflurane. Mice were administrated with 1 mCi [18F] fluoro-2-deoxyglu-
cose ([18F] FDG) via tail vein injection and subjected to an 80 min dynamic
scan. Data analysis was performed using the InveonResearchWorkplace soft-
ware to determine the standardized uptake values (SUVs) (activity concentra-
tion/injected dose 3 body weight) based on drawn ROIs at the end of the
80 min scanning period. Computed tomography (CT) with hindlimbs centered
in the field of view was performed before the microPET imaging. Recon-
structedCT imageswere registeredwithmicroPET images to precisely identify
TA muscles on hindlimbs. To activate brown adipocytes, a b3-adrenergic
selective agonist, CL-316,243, was administrated (1 mg/kg body weight; i.p.
injection) 20 min before the anesthesia.
Thermographic Imaging
Mouse thermographic imaging was performed with a FLIR T640 infrared
camera with highest sensitivity set to35C. Control or miR-133 ASO-treated
C57BL/6male mice fed with either a regular diet or a HFD were shaved at both
of the hindlimbs 1 day before the imaging. Subject mice were quickly anesthe-
tized under 1% isoflurane, and thermographic images were taken immedi-
ately after the mice were anesthetized (within 2 min). Data analysis was
performed using FLIR QuickReport software with measuring crosses set on
the TA muscle areas on lower hindlimbs and the neck areas.
Statistical Analysis
Error bars are SEM. Asterisk indicates significant pairwise comparison by t
test, *p% 0.05, **p% 0.01, ***p% 0.001.
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